KATHLEEN COMER: Open Payments
NPI 1689778755 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 7 payments from 5 companies in 2025. Trend: 2023 $707 · 2024 $1,281 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Alkermes, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
Products named: CAPLYTA, ARISTADA, Auvelity, AUSTEDO XR, VRAYLAR.
Industry payments across CA — which companies pay providers there.
